44 results on '"London, G"'
Search Results
2. P1584The prognostic significance of the blood pressure-pulse wave velocity association for cardiovascular outcomes and mortality in hemodialysis patients
3. FP402RELATIVE RISK OF MORTALITY IN HEMODIALYSIS PATIENTS PRESCRIBED CALCIUM-FREE AND CALCIUM-CONTAINING PHOSPHATE BINDING AGENTS
4. FP473THE USE OF HIGH-FLUX MEMBRANES IS NOT ASSOCIATED WITH IMPROVED SURVIVAL OF PATIENTS ON HEMODIALYSIS
5. Con: Vascular calcification is a surrogate marker, but not the cause of ongoing vascular disease, and it is not a treatment target in chronic kidney disease
6. Opponent's comments
7. Assessment of arterial stiffness for clinical and epidemiological studies: methodological considerations for validation and entry into the European Renal and Cardiovascular Medicine registry
8. A European Renal Best Practice (ERBP) position statement on the Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline for the Management of Blood Pressure in Non-dialysis-dependent Chronic Kidney Disease: an endorsement with some caveats for real-life application
9. Anaemia in CKD 5D
10. Heart and bone in CKD - A
11. Renal anaemia - CKD 5D
12. Baseline characteristics of subjects enrolled in the Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) trial
13. Predictive value of circulating endothelial microparticles for cardiovascular mortality in end-stage renal failure: a pilot study
14. Arterial functions: how to interpret the complex physiology
15. Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guidelines: a European Renal Best Practice (ERBP) commentary statement
16. Promoting scientific collaboration and education in cardiovascular-renal medicine: EURECAM: An ERA-EDTA-based working group
17. Renal replacement therapy for heart failure patients: in whom, when and which therapy to use?
18. The future of European Nephrology 'Guidelines'--a declaration of intent by European Renal Best Practice (ERBP)
19. Biosimilars and biopharmaceuticals: what the nephrologists need to know--a position paper by the ERA-EDTA Council
20. Clinical Outcomes in Secondary Hyperparathyroidism and the Potential Role of Calcimimetics
21. Patients with complex arrhythmias during and after haemodialysis suffer from different regimens of potassium removal
22. Indapamide SR Versus Candesartan and Amlodipine in Hypertension: The X-CELLENT Study
23. Role of arterial wall properties in the pathogenesis of systolic hypertension
24. Antihypertensive efficacy of indapamide SR vs candesartan and amlodipine in isolated systolic hypertensive patients
25. Left ventricular hypertrophy: why does it happen?
26. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality
27. Impairment of arterial function in chronic renal disease: prognostic impact and therapeutic approach
28. Arterial structure and function in end-stage renal disease
29. Prognostic application of arterial stiffness: task forces
30. Pathophysiology of cardiovascular damage in the early renal population
31. Arterial function in renal failure
32. The concept of ventricular/vascular coupling: functional and structural alterations of the heart and arterial vessels go in parallel.
33. Endothelin and cardiovascular remodelling in end-stage renal disease.
34. Heterogeneity of left ventricular hypertrophy--does it have clinical implications?
35. Response to vaccination against tetanus in chronic haemodialysed patients
36. Influence of Sex and Body Weight on Forearm Hemodynamics in Patients With Sustained Essential Hypertension
37. Physical properties of the aorta and cardiac hypertrophy in essential hypertension
38. Activation of Platelets, Coagulation and Fibrinolysis in Patients on Long-Term Haemodialysis: Influence of Cuprophan and Polyacrylonitrile Membranes
39. Difference in Response of Vascular Resistance to Orthostasis in Patients with Borderline and Sustained Essential Hypertension
40. Renal and Systemic Hemodynamics in Borderline Hypertension
41. An indirect approach for the study of the elastic modulus of the brachial artery in patients with essential hypertension
42. Enhanced Brachial Artery Compliance Following Perindopril in Essential Hypertension
43. Contributive Factors to Cardiovascular Hypertrophy in Renal Failure
44. Assessment of arterial stiffness for clinical and epidemiological studies: methodological considerations for validation and entry into the European Renal and Cardiovascular Medicine registry
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.